These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3523830)

  • 1. Revised classification of the DLA loci by serological studies.
    Krumbacher K; van der Feltz MJ; Happel M; Gerlach C; Lösslein LK; Grosse-Wilde H
    Tissue Antigens; 1986 May; 27(5):262-8. PubMed ID: 3523830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint report of the Third International Workshop of Canine Immunogenetics. II. Analysis of the serological typing of cells.
    Bull RW; Vriesendorp HM; Cech R; Grosse-Wilde H; Bijma AM; Ladiges WL; Krumbacher K; Doxiadis I; Ejima H; Templeton J
    Transplantation; 1987 Jan; 43(1):154-61. PubMed ID: 3798556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of target cell determinants associated with DLA-D-locus-encoded antigens by canine cytotoxic lymphocytes.
    Raff RF; Storb R; Ladiges WC; Deeg HJ
    Transplantation; 1985 Sep; 40(3):323-8. PubMed ID: 2412323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical evidence that the DLA-B locus codes for a class II determinant expressed on all canine peripheral blood lymphocytes.
    Doxiadis I; Krumbacher K; Neefjes JJ; Ploegh HL; Grosse-Wilde H
    Exp Clin Immunogenet; 1989; 6(3):219-24. PubMed ID: 2520676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine Major Histocompatibility Complex.
    Wagner JL; Sarmiento UM; Storb R
    Tissue Antigens; 2002 Mar; 59(3):205-10. PubMed ID: 12074710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical definition of DLA-A and DLA-B gene products by one-dimensional isoelectric focusing and immunoblotting.
    Kubens BS; Krumbacher K; Grosse-Wilde H
    Eur J Immunogenet; 1995 Apr; 22(2):199-207. PubMed ID: 7605778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical analysis of glycosylated and nonglycosylated DLA class I antigens.
    van der Feltz MJ; Ploegh HL
    Immunogenetics; 1984; 19(2):95-107. PubMed ID: 6365755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dog MHC class I antigens contain beta 2-microglobulin.
    van der Feltz MJ; van der Korput HA; Giphart MJ; Westbroek DL
    Exp Clin Immunogenet; 1984; 1(1):56-9. PubMed ID: 6401141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
    Wagner JL; Works JD; Storb R
    Tissue Antigens; 1998 Oct; 52(4):397-401. PubMed ID: 9820606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-based typing reveals a novel DLA-88 allele, DLA-88*04501, in a beagle family.
    Hardt C; Ferencik S; Tak R; Hoogerbrugge PM; Wagner V; Grosse-Wilde H
    Tissue Antigens; 2006 Feb; 67(2):163-5. PubMed ID: 16441490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved method for dog leukocyte antigen 88 typing and two new major histocompatibility complex class I alleles, DLA-88*01101 and DLA-88*01201.
    Venkataraman GM; Stroup P; Graves SS; Storb R
    Tissue Antigens; 2007 Jul; 70(1):53-7. PubMed ID: 17559581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity to DLA and non-DLA antigens measured by a microcytotoxicity assay in dog families.
    Gluckman JC; Robine S; Chevalier G
    Cell Immunol; 1979 Mar; 43(2):271-81. PubMed ID: 314341
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenetic aspects of a canine breeding colony.
    Ladiges WC; Deeg HJ; Raff RF; Storb R
    Lab Anim Sci; 1985 Feb; 35(1):58-62. PubMed ID: 2580117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted dog leucocyte antigen (DLA) class II haplotypes and genotypes in Beagles.
    Soutter F; Kennedy LJ; Ollier WE; Solano-Gallego L; Catchpole B
    Vet J; 2015 Mar; 203(3):345-7. PubMed ID: 25634081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DLA-associated polymorphic cell surface determinant defined by the murine monoclonal antibody W3G10.
    Ladiges WC; Raff RF; Storb R
    Anim Genet; 1987; 18(2):149-58. PubMed ID: 2444142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomenclature for factors of the dog major histocompatibility system (DLA), 1998: first report of the ISAG DLA Nomenclature Committee.
    Kennedy LJ; Altet L; Angles JM; Barnes A; Carter SD; Francino O; Gerlach JA; Happ GM; Ollier WE; Polvi A; Thomson W; Wagner JL
    Anim Genet; 2000 Feb; 31(1):52-61. PubMed ID: 10690362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organization of the canine major histocompatibility complex: current perspectives.
    Wagner JL; Burnett RC; Storb R
    J Hered; 1999; 90(1):35-8. PubMed ID: 9987900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of class II alpha genes and DLA-D region allelic associations in the dog.
    Sarmiento UM; Storb RF
    Tissue Antigens; 1988 Oct; 32(4):224-34. PubMed ID: 2905843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow grafts between phenotypically DLA-identical and haploidentical unrelated dogs: additional antigens controlling engraftment are not detected by cell-mediated lympholysis.
    Deeg HJ; Storb R; Raff RF; Weiden PL; DeRose S; Thomas ED
    Transplantation; 1982 Jan; 33(1):17-21. PubMed ID: 7039018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution characterization of the canine DLA-DRB1 locus using reference strand-mediated conformational analysis.
    Kennedy LJ; Quarmby S; Fretwell N; Martin AJ; Jones PG; Jones CA; Ollier WE
    J Hered; 2005; 96(7):836-42. PubMed ID: 16251520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.